2013
Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.
PAGANO, Livio; Oliver A. CORNELY; Alessandro BUSCA; Morena CAIRA; Simone CESARO et. al.Základní údaje
Originální název
Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.
Autoři
PAGANO, Livio; Oliver A. CORNELY; Alessandro BUSCA; Morena CAIRA; Simone CESARO; Cristiana GASBARRINO; Corrado GIRMENIA; Werner J. HEINZ; Raoul HERBRECHT; Cornelia LASS-FLÖRL; Annamaria NOSARI; Leonardo POTENZA; Zdeněk RÁČIL; Volker RICKERTS; Donald C. SHEPPARD; Arne SIMON; Andrew J. ULLMAN; Caterina Giovanna VALENTINI; Jörg Janne VEHRESCHILD; Anna CANDONI a Maria J.G.T. VEHRESCHILD
Vydání
Haematologica, Pavia, ITALY, Ferrata Storti Foundation, 2013, 0390-6078
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Itálie
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.868
Kód RIV
RIV/00216224:14740/13:00069044
Organizační jednotka
Středoevropský technologický institut
UT WoS
000328543400002
Klíčová slova anglicky
posaconazole; lipid fomulations of amphotericin B; Mucormycosis; combination therapy; invasive fungal infections; hematological malignancies
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 28. 4. 2014 16:01, Olga Křížová
Anotace
V originále
Our case series may have been subject to selection bias, as only those patients who survived long enough to receive a combination therapy were included. However, since interventional trials on this question are unlikely to be performed any time soon, data from registries remain the only available source of structured information on the treatment of mucormycosis. In conclusion, our analysis suggests that a combined antifungal treatment with Lip-AmB+POS may be considered in patients with very aggressive forms of IM.